PMID: 9653096Jul 7, 1998Paper

Cytotoxic T lymphocyte antigen 4 (CTLA4) blockade accelerates the acute rejection of cardiac allografts in CD28-deficient mice: CTLA4 can function independently of CD28

The Journal of Experimental Medicine
H LinM L Alegre

Abstract

Cytotoxic T lymphocyte antigen 4 (CTLA4) appears to negatively regulate T cell activation. One mechanism by which CTLA4 might antagonize T cell function is through inhibition of CD28 signaling by competing for their shared ligands B7-1 and B7-2. In addition, CTLA4 ligation could initiate a signaling cascade that inhibits T cell activation. To address whether CTLA4 could inhibit immune responses in the absence of CD28, rejection of heart allografts was studied in CD28-deficient mice. H-2(q) hearts were transplanted into allogeneic wild-type or CD28-deficient mice (H-2(b)). Graft rejection was delayed in CD28-deficient compared with wild-type mice. Treatment of wild-type recipients with CTLA4-immunoglobulin (Ig), or with anti-B7-1 plus anti-B7-2 mAbs significantly prolonged allograft survival. In contrast, treatment of CD28-deficient mice with CTLA4-Ig, anti-B7-1 plus anti-B7-2 mAbs, or a blocking anti-CTLA4 mAb induced acceleration of allograft rejection. This increased rate of graft rejection was associated with more severe mononuclear cell infiltration and enhanced levels of IFN-gamma and IL-6 transcripts in donor hearts of untreated wild-type and CTLA4-Ig- or anti-CTLA4 mAb-treated CD28-deficient mice. Thus, the negative regu...Continue Reading

References

Sep 1, 1994·Immunity·J M GreenC B Thompson
Jan 1, 1995·The Journal of Experimental Medicine·H SchneiderC E Rudd
Aug 1, 1994·Immunity·T L WalunasJ A Bluestone
Mar 22, 1996·Science·D R LeachJ P Allison
Feb 15, 1996·Transplantation·K KawaiP S Ohashi
Jun 1, 1996·The Journal of Experimental Medicine·M F Krummel, J P Allison
Jun 1, 1996·The Journal of Experimental Medicine·T L WalunasJ A Bluestone
Jan 1, 1996·Annual Review of Immunology·D J LenschowJ A Bluestone
Jan 1, 1996·Immunologic Research·T A JudgeL A Turka
Apr 7, 1997·The Journal of Experimental Medicine·Y WuY Liu
May 27, 1997·Transplantation·T C PearsonC P Larsen
Jul 21, 1997·The Journal of Experimental Medicine·K McCoyG L Gros
Mar 21, 1998·The Journal of Experimental Medicine·F LühderD Mathis

❮ Previous
Next ❯

Citations

Mar 29, 2002·European Journal of Immunology·Todd N EagarStephen D Miller
Jul 10, 2007·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Daniel FabianThomas Ritter
Mar 27, 2001·Transplantation Proceedings·M AlegreJ Bluestone
Jun 27, 2001·Lancet·X YuC Anasetti
Aug 17, 2002·Current Opinion in Immunology·Thomas WekerleMegan Sykes
Oct 6, 1999·Current Opinion in Immunology·Z Dai, F G Lakkis
Apr 21, 1999·Current Opinion in Cell Biology·C A Chambers, J P Allison
Oct 6, 2001·Trends in Parasitology·N A Gomes, G A DosReis
Mar 22, 2002·Nature Reviews. Immunology·M L AlegreC B Thompson
Jan 26, 2008·Nature Reviews. Immunology·Christopher E Rudd
Apr 2, 1999·Immunology and Cell Biology·K D McCoy, G Le Gros
Oct 19, 2005·The Journal of Experimental Medicine·Hongsi JiangYoshinori Fukui
Jan 12, 2000·Current Opinion in Nephrology and Hypertension·C van Kooten
Sep 24, 2005·Transplantation·Michael R Clarkson, Mohamed H Sayegh
Mar 23, 2006·Annual Review of Immunology·Wendy A TeftJoaquín Madrenas
Sep 30, 1999·American Journal of Respiratory Cell and Molecular Biology·M MathurP Padrid
Mar 1, 2000·American Journal of Respiratory Cell and Molecular Biology·J M Green
May 15, 2001·American Journal of Respiratory Cell and Molecular Biology·J S BurrJ M Green
Mar 10, 2001·The Journal of Clinical Investigation·T ChitnisS J Khoury
Apr 4, 2001·The Journal of Clinical Investigation·D A MandelbrotA H Sharpe
Jul 17, 2003·The Journal of Clinical Investigation·Hiroshi HaradaMohamed H Sayegh
Dec 21, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ahmad A TarhiniJohn M Kirkwood
Nov 19, 2009·Cell Transplantation·Jun SuzukiZhibin Chen
Jul 21, 1999·Proceedings of the National Academy of Sciences of the United States of America·C A ChambersJ P Allison
Oct 18, 2000·Proceedings of the National Academy of Sciences of the United States of America·F LuhderD Mathis
Sep 10, 2005·Proceedings of the National Academy of Sciences of the United States of America·Masayuki ShoDavid M Rothstein
Jun 29, 2001·Transplant Infectious Disease : an Official Journal of the Transplantation Society·A D Kirk
Jan 8, 2005·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Sigrid E SandnerMohamed H Sayegh

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Related Papers

American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Alan D Salama, M Sayegh
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons
G L SzotM L Alegre
© 2022 Meta ULC. All rights reserved